Literature DB >> 9510382

Orbitofrontal function, object alternation and perseveration.

M Freedman1, S Black, P Ebert, M Binns.   

Abstract

Object alternation (OA) is a well-established measure of perseveration and orbitofrontal function in non-human primates. Although several studies have used OA to examine orbitofrontal system dysfunction in humans with neurological and psychiatric disease, this task itself has not been validated as a bona fide measure of frontal dysfunction in humans. To address this issue, six patients with bilateral frontal lobe lesions documented by computerized tomography (CT) or magnetic resonance imaging (MRI) and 15 healthy controls were given OA, as well as other measures of frontal system dysfunction, delayed alternation (DA), delayed response (DR), and the Wisconsin Card Sorting Test (WCST). The CT and MRI scans were interpreted blindly. The patients with bilateral frontal lesions were significantly impaired on OA, DA, DR and the WCST. Analyses of the CT/MRI lesions suggest that the neuroanatomical regions involved in the deficits on OA include Brodmann areas 10, 24, 32 and 47, as well as possibly 11, and that OA is a sensitive measure of ventrolateral-orbitofrontal and medial frontal dysfunction in humans. Our findings lend further support for the use of experimental paradigms adopted from animal models to study the functional neuroanatomy and neuropsychological mechanisms underlying cognitive functions in humans with neurological and psychiatric disease.

Entities:  

Mesh:

Year:  1998        PMID: 9510382     DOI: 10.1093/cercor/8.1.18

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  40 in total

1.  Functional anatomy of execution, mental simulation, observation, and verb generation of actions: a meta-analysis.

Authors:  J Grèzes; J Decety
Journal:  Hum Brain Mapp       Date:  2001-01       Impact factor: 5.038

Review 2.  Frontal lobe functions.

Authors:  C Chayer; M Freedman
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 5.081

3.  Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance.

Authors:  Roshan Cools; Luke Clark; Trevor W Robbins
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

4.  Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence.

Authors:  Emily R Hankosky; Joshua M Gulley
Journal:  Dev Psychobiol       Date:  2012-07-06       Impact factor: 3.038

5.  Prefrontal serotonin depletion affects reversal learning but not attentional set shifting.

Authors:  H F Clarke; S C Walker; H S Crofts; J W Dalley; T W Robbins; A C Roberts
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

6.  Inhibition of Action, Thought, and Emotion: A Selective Neurobiological Review.

Authors:  Daniel G Dillon; Diego A Pizzagalli
Journal:  Appl Prev Psychol       Date:  2007-12

7.  Prefrontal Computation as Active Inference.

Authors:  Thomas Parr; Rajeev Vijay Rikhye; Michael M Halassa; Karl J Friston
Journal:  Cereb Cortex       Date:  2020-03-21       Impact factor: 5.357

8.  Effects of dietary management of phenylketonuria on long-term cognitive outcome.

Authors:  Shelley Channon; Galya Goodman; Sally Zlotowitz; Caroline Mockler; Philip J Lee
Journal:  Arch Dis Child       Date:  2006-10-26       Impact factor: 3.791

9.  The Toronto prehospital hypertonic resuscitation-head injury and multi organ dysfunction trial (TOPHR HIT)--methods and data collection tools.

Authors:  Laurie J Morrison; Sandro B Rizoli; Brian Schwartz; Shawn G Rhind; Merita Simitciu; Tyrone Perreira; Russell Macdonald; Anna Trompeo; Donald T Stuss; Sandra E Black; Alex Kiss; Andrew J Baker
Journal:  Trials       Date:  2009-11-20       Impact factor: 2.279

10.  Rule knowledge aids performance on spatial and object alternation tasks by alcoholic patients with and without Korsakoff's amnesia.

Authors:  Fiona J Bardenhagen; Marlene Oscar-Berman; Stephen C Bowden
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.